See what you missed at ASRM 2024 with the ASRM 2024 Recorded Bundle
Preimplantation genetic testing for polygenic disorders (PGT-P) has been commercially available since 2019. PGT-P makes use of polygenic risk scores for conditions which are multifactorial and
The intake of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in obese women with PCOS demonstrated improvement in metabolic and reproductive symptoms; however, their impact in non-PCOS
This study investigated whether luteinizing hormone receptor (LHR) expression varies in the granulosa cells of individual follicles according to the maturation stage of the oocytes harvested for
Hereditary hemochromatosis (HH) is a common genetic disorder characterized by iron overload, which, if undiagnosed, can lead to severe organ damage. There are four types of HH. Type 1 HH, the
To study the structural and human factors that negatively and positively influence the patient experience during assisted reproductive technology (ART) treatment.
Human embryonic aneuploidy may represent one of the final frontiers in assisted reproductive technology, primarily secondary to oocyte aneuploidy. Mammalian oocytes possess unique characteristics
To use murine avatars for studying human endometriotic lesion response to 2 different hormonal regimens to determine whether progesterone receptor (PR) can prospectively predict response to
To compare in vitro fertilization treatment outcomes for the oral gonadotropin-releasing hormone (GnRH) antagonist elagolix (E) to the conventionally used injectable GnRH antagonist ganirelix (G)
On behalf of our coinvestigators, we write to respond to concerns raised about the presentation of data published alongside our article, “High rate of isolated teratospermia in a population of
To investigate whether idiopathic nonobstructive azoospermia (iNOA) has its own transcriptomic signature.
Displaying 21 to 30 of 1649 records
